The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
April 29th 2025
Integrating community pharmacists into specialty pharmacy care can enhance patient access, address physician shortages, and expand pharmacists' roles in delivering high-quality clinical services, according to experts at Asembia’s AXS25 Summit.
Headaches May Indicate Other Conditions
June 3rd 2019Elizabeth K Rende DNP, RN, CPNP-PC, PMHS-BC, FAANP of Duke Pediatric Neurology discussed 2 types of headaches—primary and secondary—in an interview filmed at the 2019 National Association of Pediatric Nurse Practitioners conference in New Orleans.
Watch
Addressing Common Concerns with Fever
June 2nd 2019Mary Jean Ohns, DNP, APRN, CPNP, CCRN, of Toledo Children's Hospital addresses frequent concerns that parents express when a child has a fever, in an interview filmed during the 2019 National Association of Pediatric Nurse Practitioners annual conference in New Orleans.
Watch
Ongoing Outbreaks Put Measles Elimination Status at Risk in the United States
May 31st 2019The CDC has indicated that many recent measles cases reported in the United States in 2018 have been the result of international travel to areas of the world where the virus is active, and individuals who are not vaccinated against the virus.
Read More
FDA Seeks Feedback on Potential Special Packaging Requirement for Certain Opioid Medications
May 31st 2019The agency has opened a public docket to solicit feedback on the proposed requirement, which would necessitate certain immediate-release opioid analgesics be made available in fixed-quantity, unite-of-use blister packaging.
Read More
Common Challenges and Barriers to Patients in Accessing Medication
May 29th 2019Matthew Pickering, PharmD, RPh, PQA Senior Director of Research & Quality Strategies at Pharmacy Quality Alliance discusses its medication access framework for quality measurement during the Pharmacy Quality Alliance Annual Meeting in Baltimore, MD.
Watch
Lenalidomide, Rituximab Combo Granted FDA Approval for Indolent Non-Hodgkin Lymphoma
May 28th 2019The approval of R2 is based on data from the phase 3 AUGMENT study evaluating the safety and efficacy of the combination regimen compared with rituximab plus placebo in patients with previously-treated FL and MZL.
Read More
FDA Expands Use of Cariprazine to Include Treatment of Depressive Episodes
May 28th 2019The new indication makes cariprazine (Vraylar, Allergan and Gedeon Richter) the first and only dopamine and serotonin partial agonist to treat the full spectrum of bipolar I symptoms in manic, mixed, and depressive episodes, according to the companies.
Read More